The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
HIV treatment that can be injected every one or two months has been approved for use in some countries. What does it mean for people with HIV across the world?
Dutch study finds no evidence to suggest PrEP use increases mental health issues – and may actually help reduce sexual compulsivity and drug-misuse.
People on integrase inhibitors found to gain more weight on average than those on other treatment regimens
UK efforts to end the HIV epidemic by 2030 are advancing, but challenges remain around reaching those undiagnosed and those diagnosed late.
Decade-long Canadian study of people who inject drugs reports high number of premature deaths – but finds those who regularly use supervised injection facilities are significantly less likely to die.
Switching from an antiretroviral treatment (ART) regimen containing tenofovir disoproxil fumarate (TDF) to a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide (ECETA) can improve bone density and kidney safety in those aged 60 and above, new study finds.
New study supports the use of dating apps and social media to communicate sexual health information to gay men in England.
Baseline HIV testing data reveals sub-optimal testing rates among those living in the most heavily burdened areas of the USA.
Screening for intimate partner violence should form part of sexual health services to reach vulnerable gay men.
New analysis from the US CDC quantifies the number of new HIV infections that might have been prevented in the absence of racial disparities, indicating how the effects of race on HIV infection may be changing